We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

RecipharmCobra Biologics Announces Successful Pre-Clinical TB Vaccine Results using its Oral Vaccine Delivery Platform (ORT-VAC™)

News   Jan 13, 2011

 
RecipharmCobra Biologics Announces Successful Pre-Clinical TB Vaccine Results using its Oral Vaccine Delivery Platform (ORT-VAC™)
 
 
 

RELATED ARTICLES

Study Suggests a Lack of Racial Diversity in Cancer Drug Trials

News

A new study has found that fewer than 8% of cancer drug trials reported participation from the four major races in the United States – white, Asian, black and Hispanic – between 2008 and 2018.

READ MORE

Ebola Patients Have a 90% Survival Rate After Injection With New Drugs

News

Two Ebola drugs have proven so effective in a clinical trial that researchers will make the treatments available to anyone infected with the virus in the Democratic Republic of the Congo, where Ebola has killed nearly 1,900 people over the past year.

READ MORE

Nanoparticle Drugs Pass Through Lymphatics to Destroy Metastases

News

Researchers have developed a strategy to target metastases residing in the lymph nodes, destroying them before they can cause cancer at other locations.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE